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Abstract
Background: The feasibility of absolute myocardial blood flow quantification and suitability of hyperpolarized
[1-13C] pyruvate as contrast agent for first-pass cardiovascular magnetic resonance (CMR) perfusion measurements
are investigated with simulations and demonstrated in vivo in a swine model.
Methods: A versatile simulation framework for hyperpolarized CMR subject to physical, physiological and technical
constraints was developed and applied to investigate experimental conditions for accurate perfusion CMR with
hyperpolarized [1-13C] pyruvate. Absolute and semi-quantitative perfusion indices were analyzed with respect to
experimental parameter variations and different signal-to-noise ratio (SNR) levels. Absolute myocardial blood flow
quantification was implemented with an iterative deconvolution approach based on Fermi functions. To demonstrate
in vivo feasibility, velocity-selective excitation with an echo-planar imaging readout was used to acquire dynamic
myocardial stress perfusion images in four healthy swine. Arterial input functions were extracted from an additional
image slice with conventional excitation that was acquired within the same heartbeat.
Results: Simulations suggest that obtainable SNR and B0 inhomogeneity in vivo are sufficient for the determination of
absolute and semi-quantitative perfusion with ≤25% error. It is shown that for expected metabolic conversion rates,
metabolic conversion of pyruvate can be neglected over the short duration of acquisition in first-pass perfusion CMR.
In vivo measurements suggest that absolute myocardial blood flow quantification using hyperpolarized [1-13C]
pyruvate is feasible with an intra-myocardial variability comparable to semi-quantitative perfusion indices.
Conclusion: The feasibility of quantitative hyperpolarized first-pass perfusion CMR using [1-13C] pyruvate has
been investigated in simulations and demonstrated in swine. Using an approved and metabolically active
compound is envisioned to increase the value of hyperpolarized perfusion CMR in patients.
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Background
Qualitative and semi-quantitative myocardial perfusion
cardiovascular magnetic resonance (CMR) imaging using
gadolinium based contrast agents is a clinically estab-
lished modality for diagnosing coronary artery disease
and ischemia [1, 2]. To reduce operator dependence dur-
ing analysis and to enable the assessment of triple-vessel
disease, microvascular obstruction and other conditions
that present themselves by global or diffuse perfusion
deficits, absolute myocardial blood flow (MBF) quantifi-
cation is promoted [3, 4]. Absolute MBF quantification
requires an accurate estimation of the impulse response
function (IRF), which links the concentration of an
arterial input function (AIF) and the response concen-
tration in the myocardium, and scales linearly with the
MBF. In conventional first-pass perfusion CMR bolus
administration of chelated gadolinium-based contrast
agents is used to accelerate spin-lattice relaxation sub-
ject to contrast agent concentration. The resulting dy-
namic contrast enhancement (DCE) provides contrast
between ischemic and normally perfused myocardial tis-
sue [5, 6] with commonly used saturation recovery se-
quences [7]. However, determination of contrast agent
concentrations from measured signal intensities is com-
plicated by the non-linearity of spin-lattice relaxation
and saturation effects during acquisition. To address
these issues, dual-bolus [5, 8] or variable saturation delay
[9] approaches have been proposed at the cost of add-
itional bolus administrations and/or non-trivial correc-
tion steps.
Dissolution dynamic nuclear polarization enables the
production of highly polarized endogenous 13C labelled
molecules in solution with > 10,000-fold enhanced signal
relative to thermal equilibrium [10]. We have previously
demonstrated the feasibility of hyperpolarized first-pass
perfusion CMR using 13C urea in porcine models [11].
Due to the lack of thermal background signal, hyperpo-
larized contrast agents benefit from high contrast to
noise ratio (CNR) compared with gadolinium-based
measurements, as well as linear dependency of signal in-
tensity with respect to concentration, which makes them
promising alternatives for absolute MBF quantification.
To avoid unwanted effects from metabolic conversion,
hyperpolarized perfusion imaging has so far been limited
to 13C urea and other metabolically inert substrates such
as HP001 [12], tert-butanol [13] or α-trideuteromethyl
[15N] glutamine [14].
Pyruvate is metabolically active and a vital intermedi-
ate in the process of glycolysis, where it is converted into
lactate, carbon dioxide (C02)/ bicarbonate and alanine.
As a hyperpolarized substrate, [1-13C] pyruvate has been
widely used to probe the glycolytic pathway in various
organs of the body, including the heart [15–17]. To bet-
ter understand the pathological alterations in
metabolism and to improve diagnostic value, quantifica-
tion of the metabolic conversion rates in form of kinetic
modelling has been applied in tumours [18, 19] and the
isolated and in-vivo rat heart [20, 21]. This approach
however requires accurate knowledge of the bolus input
in the target organ for quantification and discrimination
of metabolic and perfusion related signal variations. To
this end tailored blood suppressing sequences and
co-polarized administration of [13C] urea have been pro-
posed [22, 23].
With recent progress in the translation of hyperpolar-
ized [1-13C] pyruvate into clinical application [24] and
first successful administrations in the human heart [25],
the need for accurate perfusion assessment without add-
itional measurements has been highlighted. Extensive
alterations and global as well as diffuse deficits are only
detectable by quantitative assessment of metabolic pro-
cesses with kinetic modelling and knowledge of the
underlying perfusion. As regulatory approval of hyperpo-
larized substrates for human administration is limited to
[1-13C] pyruvate for the foreseeable future, previously
proposed perfusion substrates are currently not suited
for clinical trials.
In this work we therefore explore the feasibility and
accuracy of absolute and semi-quantitative perfusion
CMR using [1-13C] pyruvate. By administration of a
sharp contrast agent bolus and using velocity-selective
excitation [11], we show that myocardial perfusion can
rapidly be assessed before metabolic conversion signifi-
cantly alters myocardial pyruvate signal intensities.
Extensive simulations including MBF, metabolic conver-
sion and physical imaging constraints inform on the lim-
itations and requirements for accurate determination of
absolute and semi-quantitative perfusion indices. In vivo
feasibility and absolute MBF quantification is demon-
strated in a swine model.
Methods
Simulation framework
A high resolution computational model of a short axis
view of the heart was generated from the MRXCAT phan-
tom [26] at a field-of-view (FOV) of 120 × 120 mm2. To
account for limited sampling resolution and intra-slice ef-
fects, the initial phantom consists of three slices of 3 mm
thickness with an in-plane resolution of 1 × 1 mm2. A total
of eight anatomical compartments were defined based on
the mid left ventricular (LV) slice of the American Heart
Association (AHA) segmentation [27]: right ventricular
(RV) blood pool, LV blood pool and six myocardial seg-
ments. K-space sampling subject to several physical and
physiological effects were then modeled as illustrated in
Fig. 1. The full signal model for the presented simulation
framework for sampling one 2D slice consisting of 3 iso-
chromat sub-slices is given by:
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where r
*¼ ðx; y; zÞT and k*¼ ðkx; ky; kzÞT denote the
spatial coordinates in image space and k-space respect-
ively, td the time point in the dynamic series, α the
spatially varying flip angle, Cm, fm, T1, m the concentra-
tion, frequency offset and longitudinal relaxation time of
metabolite m, and B0, T

2;m the off-resonance and appar-
ent transverse relaxation times. The time dependent k-
space trajectoryk(ts) with sampling time points ts enables
Fig. 1 Simulation pipeline overview. Dynamic cardiac perfusion image series are generated from a six sector MRXCAT model in short axis view.
Concentration dynamics are calculated from a convolutional perfusion model and a first order kinetic model for metabolic conversion. Spatial
variation of B0 inhomogeneities, T2* relaxation and excitation profiles are included as synthetic maps. K-space sampling is implemented for arbitrary
trajectories with phase evolutions for each sampling time point. Three high resolution slices are down-sampled into one image slice. Perfusion curves
are extracted from noisy images at eight different signal-to-noise (SNR) levels with 20 realizations each
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k-space sampling along arbitrary trajectories and at arbi-
trary resolutions considering dephasing effects during
the readout.
Dynamic pyruvate concentrations were simulated in
a two-step process: Firstly, MBF was modeled by con-
volution of a generic AIF from the MRXCAT model
in the LV with a Fermi function shaped IRF:
Cmyo tð Þ ¼ IRF tð Þ  AIFLV tð Þ
IRF tð Þ ¼ MBF  1þ β
1þ βeαt
ð2Þ
with shape parameters α, β = 0.25, temporal sampling
interval 0.5 s (heart rate 120 bpm) and varying MBF. In
a second step, a forward kinetic model was employed to
account for metabolic conversion of pyruvate (Pyr) into
lactate (Lac) and bicarbonate (Bic):
d
dt
CPyr tð Þ
CLac tð Þ
CBic tð Þ
2
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Where kPL, kPB denote the kinetic forward conversion
rates from pyruvate into lactate and bicarbonate, re-
spectively. Reverse conversion from lactate to pyruvate
was assumed negligible (kLP = 0).
Off-resonances were simulated as a high resolution B0
map generated from a superposition of a three-dimensional
second order polynomial and a filtered replica of the ana-
tomical model. A convolution of the anatomical object with
a Laplacian of Gaussian filter (width 8 mm, σ = 2 mm) was
used to create an object that mimics strong susceptibility
gradients at tissue interfaces as described in [28]. The com-
bined B0 map was then scaled to the desired maximum
in-plane and through-slice off-resonance.
B0 x; y; zð Þ ¼ LoG x; yð Þ Myoz x; yð Þ
þ f poly x; y; zð Þ þ Bdz zð Þ ð4Þ
where LoG denotes the filter kernel, Myoz the myocar-
dial object mask, fpoly the 3D 2nd order polynomial and
Bdz the B0 through-slice gradient.
Spatially varying T2* relaxation was calculated from
the first order derivative of the B0 map along phase and
measurement direction using a 2D Gaussian kernel (σ =
3):
1
T2;m x; yð Þ
¼ 1
T2;m
þ GΔx  B0 x; yð Þ þ GΔy
 B0 x; yð Þ ð5Þ
With T2, m the native T2 of metabolite m, and GΔx,
GΔy the 2D Gaussian kernels along x and y, respectively.
Velocity-selective excitation [11] was simulated assum-
ing a parabolic velocity distribution in the RV and LV ac-
cording to:
v x; yð Þ ¼ vmax
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
2w
x−xcð Þ2
 2
þ 1
2w
y−ycð Þ2
 2s
ð6Þ
where w denotes the width of the distribution and (xc, yc)
the center of mass of the respective blood compartment.
Based on the velocity distribution, the effective spatially
dependent flip angle of the selective excitation is given
by:
αeff x; yð Þ ¼ α  sin venc−v x; yð Þvenc
π
2
 
 ð7Þ
where α denotes the nominal flip angle and venc the en-
coding velocity of the excitation.
An echo planar imaging (EPI) trajectory for k-space
sampling was generated from gradient waveforms with
hardware limits in accordance to in vivo experiments on
a clinical 3 T system (slew rate 195 T/m/s, amplitude 30
mT/m). Using Partial Fourier acquisition (factor 0.65)
the effective number of profiles was reduced from 39 to
25, resulting in a readout duration of 35 ms for the tar-
get in-plane resolution of 3 × 3 mm2 and a 120 × 120
mm2 FOV.
Computationally the proposed model as described by
Equation (1) is challenging, due to the inclusion of the
phase evolution stemming from B0 inhomogeneities.
Consequently, the resulting phase maps need to be cal-
culated for each k-space sampling time point ts, which
significantly increases the memory requirements. The
simulation of a dynamic k-space series with 40 dynamics
took approximately 5 min on a workstation equipped
with a hexa-core Xeon X5670 processor and 256 GB of
memory.
In order to assess the sensitivity and to inform on
practical limitations of hyperpolarized perfusion mea-
surements, pivotal simulation parameters were varied
over their respectively expected value ranges in vivo.
Table 1 shows the parameters in the defined reference
case (BASE) as well as their respective sweep ranges.
Static parameters were set to: α = 60°, venc = 0.35 m/s,
w = 0.2 m. T1/T2 values for pyruvate, lactate and bicar-
bonate were set to 30/0.1 s, 20/0.1 s and 20/0.15 s, re-
spectively. T1 values were chosen based on separate
experiments outlined below. In absence of available T2
values for cardiac tissue, conservative estimations were
used based on hepatic tissue in rats [29]. For each simu-
lation according to Equation (1) and Table 1, a second
simulation was performed with a constant flip angle of
Fuetterer et al. Journal of Cardiovascular Magnetic Resonance           (2018) 20:73 Page 4 of 15
5° to assess the parameter impact on AIF measurements
in vivo.
Simulation post-processing
A total of 8 signal-to-noise ratio (SNR) levels were simu-
lated: 5, 7.5, 10, 15, 20, 30, 40, 50. For each SNR level 20
realizations of noise were computed with respect to
mean peak myocardial signal. Signal curves for the six
AHA sectors and the AIF were then extracted, corrected
for T1 relaxation and baseline corrected. AIF signals
were scaled to compensate for the flip angle difference.
For all myocardial sectors, the area-under-the-curve
(AUC) and upslope parameters were calculated. The
AUC was calculated by signal integration from AIF peak
to myocardial peak, whereas upslope was determined by
fitting a linear slope over 5 time points centered between
AIF peak and myocardial peak signal.
MBF quantification was performed by iterative fitting
of the IRF in Equation (2) for varying time shifts as pro-
posed by Wissmann et al. [30]. Prior to quantification, a
three-parameter gamma variate function was fitted to
the AIF signal according to Equation (8) to compensate
for the insufficient sampling rate and to reflect the treat-
ment of in vivo data described in the data post-processing
section. Absolute MBF was then calculated from fitted
AIF signals and up-sampled myocardial signals as de-
scribed below for in vivo data post-processing.
Hyperpolarization and in vivo CMR
In vivo measurements were performed on a clinical 3 T
wide-bore scanner (Ingenia, Philips Healthcare, Best,
The Netherlands) equipped with a gradient system deliv-
ering 30 mT/m maximum amplitude at 195 T/m/s slew
rate. A custom coil array with 6 13C and 2 1H receive
channels was used for signal reception (Rapid Biomed-
ical, Rimpar, Germany). Animals were placed in right re-
cumbency inside the scanner and an electrocardiogram
(ECG) unit was used for cardiac synchronization.
Samples of 0.75 mL neat pyruvic acid were doped with
15 mM AH111501 trityl radical and polarized for 3.5 h
in a commercial 5 T SpinLab Polarizer (General Electric
Healthcare, Waukesha, Wisconsin, USA) before dissolution
in a buffer of 25 mL 0.1% EDTA water solution. Upon
sample collection, the prepared solution was neutralized
and diluted with 10.85 g of 0.72 M NaOH solution and
4.5 mL buffer solution at 0 °C to achieve a final injection
medium with a pH value of 7 at body temperature. 25 mL
of the final 300 mM 13C pyruvate solution were bolus
injected over 2 s through femoral venous catheters 20 s
after dissolution. Polarization levels and T1 relaxation
times of the neat solution inside the 3 T magnetic field
were established in separate experiments as 54 ± 3% and
71 ± 3 s, respectively. In vivo T1 relaxation times were de-
termined to 32 ± 3 s, based on 3 measurements of hyper-
polarized pyruvate solution diluted in porcine blood at a
ratio of 1:10.
Animal handling
Four healthy female swine (Edelschwein, weight 30–35 kg)
were used for the experiments. After induction of general
anesthesia, all swine were intubated and sheaths (5 F)
were introduced into both femoral arteries and veins.
100 IU/kg unfractionated heparin was given intravenously
and repeated every hour. General anesthesia was main-
tained with isoflurane (2–3%) by positive pressure ven-
tilation with 100% oxygen. Heart rate, rhythm and
variability, inspiratory and expiratory gases (CO2, O2,
isoflurane), pulse oximetry, temperature, direct arterial
blood pressure, urine output, and arterial and venous
blood gases were monitored throughout the procedure.
Cardiac stress was pharmacologically induced by intra-
venous administration of dobutamine (Dobutrex, TEVA
Pharma AG, Basel, Switzerland) at increasing infusion
rates until a heart rate of 120 bpm was reached (from a
baseline heart rate between 70 and 85 bpm). Upon
reaching the target heart rate, the dobutamine infusion
rate was maintained during all imaging experiments.
Three animals received a second injection of hyperpo-
larized pyruvate to assess reproducibility. After the pro-
cedure, all animals were euthanized in deep anesthesia
by lethal injection of pentobarbital.
CMR imaging
Dynamic series of 13C perfusion images in late systole
were acquired with electrocardiogram (ECG) triggering
starting five heartbeats after the start of injection to
minimize bolus saturation in the RV blood pool. Ventila-
tion was suspended for the first 45 s of imaging to avoid
misregistration between individual time frames. Velocity
selective excitation [11] was followed by an EPI readout
with parameters: FOV = 120 × 120 mm2, slice thickness
15 mm, in-plane resolution 3.0 × 3.0 mm2, TE = 13.5 ms,
TR = 1 heartbeat, FA: 60°, partial Fourier factor 0.65,
readout duration 32 ms. An additional image stack in
an apically adjacent slice with conventional excitation
(FA: 5°) was interleaved in diastole of the same heart
Table 1 Parameters investigated by simulations. BASE values
refer to the respective parameter value used for the reference
simulation. Range refers to the respectively investigated value
range for each parameter
Parameter BASE value Range [min, max] Step size
MBF [mL/min/g] 2.5 [0.5, 5.0] 0.5
B0 in-plane [ppm] 0.25 [0.0, 2.0] 0.5
Bdz through-plane [ppm] 0.0 [0.0, 1.0] 0.5
kPL [s
−1] 0.0 [0.0, 0.2] 0.05
vmax [m/s] 0.35 [0.175, 0.7] 0.175
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beat to provide AIF signal curves for absolute MBF
quantification.
All in vivo images were reconstructed from raw data
using MRecon (GyroTools LLC, Zurich, Switzerland)
and zero-filled to a common resolution of 1 × 1 mm2. 1H
images were then rotated, aligned and cropped to the
FOV of the 13C images. Nyquist-ghosts of the EPI read-
out were removed by first order phase correction maxi-
mizing signal intensity in a predefined region of interest
(e.g. LV blood pool). 13C coil combination was imple-
mented as root of weighted sum of squares [31].
Data post-processing
LV myocardium and LV blood pool were manually seg-
mented on overlays of 13C perfusion and 1H reference im-
ages. The myocardium was subsequently divided into six
segments corresponding to the basal / mid-ventricular
slices in the 16 segment AHA model [27].
Magnitude coil sensitivities were estimated by fitting a
plane over the entire FOV, using only regions with myo-
cardial signal. A time point 3 s after myocardial bolus
passage was selected to prevent overfitting of the sensi-
tivities to local perfusion deficits. The resulting sensitiv-
ity plane was then visually inspected for plausibility and
used to correct signal intensities in all previous image
frames. [1-13C] pyruvate signal intensities were calcu-
lated as mean values over each segment in the dynamic
image series, as well as the LV blood pool from the AIF
scan (scaled to compensate for different flip angles).
Myocardial signals were corrected for T1 relaxation
(T1 = 32 s) and cropped 1 s after myocardial peak signal
for quantification. Baseline offsets were corrected for by
subtraction of mean noise levels prior to bolus arrival.
Three-parameter gamma-variate functions
s tð Þ ¼ atbe−tc ð8Þ
were fitted to the measured time curves s(t) for further
analysis. Area under the curve (AUC) and up-slope were
extracted from the fitted curves as semi-quantitative per-
fusion measures [3]. SNR / CNR was calculated as mean
signal intensities divided by the standard deviation over
a noise frame after 13C signal decay [32].
Absolute MBF quantification of in vivo data was per-
formed by iterative fitting of a Fermi function as the im-
pulse response for varying time shifts between 0 and 5 s.
The first point in the time domain representation of the
solution with the smallest fitting error was taken as the
absolute MBF value and scaled to units of mL/min/g.
1H gadolinium DCE imaging
DCE perfusion CMR image series using 1H gadolinium
were acquired in three of the four subjects for prelimin-
ary validation of the proposed method. Measurements
were performed within 5 min after the last [1-13C] pyru-
vate injection. Between the 13C and 1H measurements,
dobutamine stress CMR was maintained constant. To fa-
cilitate MBF quantification, a dual-bolus approach with
0.025 mmol/kg and 0.075 mmol/kg gadolinium (Gadovist
1.0, Bayer Healthcare, Berlin, Germany) was chosen [33].
Dynamic image series were acquired every heart beat
using a saturation-recovery spoiled gradient echo se-
quence with parameters: FOV = 220 × 220 mm2,slice
thickness 10 mm, in-plane resolution 3.0 × 3.0 mm2, TR =
1.9 ms, TE = 0.7 ms, FA = 15°, WET saturation [34] delay
= 80–100 ms. A total of 100 dynamics were acquired dur-
ing suspended ventilation. Post-processing, extraction of
semi-quantitative perfusion indices and absolute MBF
quantification was performed analogous to the 13C data.
Results
Simulations
Figure 2 qualitatively illustrates the effects of limited
sampling resolution as well as variations of key parame-
ters. Increased metabolic conversion results in reduced
myocardial [1-13C] pyruvate signal with chemically
Fig. 2 Simulated perfusion images at myocardial signal peak for signal-to-noise ratio (SNR) = 15. Effects of limited sampling resolution and variation of
simulation parameters are illustrated. BASE case simulation values were: myocardial blood flow (MBF) = 2.5 mL/g/min, B0 in-plane = 0.25 ppm, B0 through-
plane = 0.0 ppm, kPL = 0.0 s
− 1, vmax = 0.35 m/s., flip-angle = 60°, in-plane resolution = 3× 3 mm
2, field-of-view 120 × 120 mm2
Fuetterer et al. Journal of Cardiovascular Magnetic Resonance           (2018) 20:73 Page 6 of 15
shifted contamination from [13C] bicarbonate and
[1-13C] lactate. In-plane B0 inhomogeneities give rise to
EPI related geometrical distortions as well as signal loss
due to intra-voxel dephasing. Through-plane B0 gradi-
ents retain geometrical accuracy but contribute to
dephasing and signal loss. Deviations between encoding
and actual blood velocities result in reduced blood pool
suppression and partial volume effects.
SNR dependency of absolute and semi-quantitative
perfusion measures are illustrated in Fig. 3 for the BASE
case. SNR levels ≥15 appear sufficient for absolute MBF
quantification within a 25% uncertainty window. A sys-
tematic under-estimation towards lower SNR levels is
apparent. Upslope appears largely insensitive to SNR
variations with accurate results at SNR ≥ 7.5. AUC values
exhibit systematic underestimation of ≥10% with outliers
even at high SNR levels.
Metabolic conversion is analyzed in Fig. 4. Increasing
kinetic rates kPL result in a reduced myocardial response
signal. For kPL ≤ 0.05 s
− 1 the up-slope remains within
25% of the reference value and the relative error of abso-
lute MBF quantification is ≤20%. AUC appears to be
linearly dependent on kPL and more strongly affected by
increased metabolic conversion than the upslope
parameter.
Figure 5 shows the results obtained for simulated ab-
solute MBF values between 0.5 and 5.0 mL /min/g. Low
simulated MBF values between 0.5 and 1.0 mL/g/min
lead to an SNR independent overestimation of 80 and
26% respectively. At higher simulated MBF values
≥3.5 mL/g/min underestimation for SNR levels < 30 is ap-
parent. Semi-quantitative perfusion indices upslope and
AUC present excellent linear dependency on simulated
MBF with little SNR dependent variation. The respective
linear regression models were calculated as MBF = 0.44 *
upslope + 0.30 for upslope-to-MBF conversion (R = 0.999
at SNR = 50) and MBF = 0.053 ⋅AUC − 0.224 for
AUC-to-MBF conversion (R = 0.999 at SNR = 50).
Impact of B0 inhomogeneities and blood pool veloci-
ties is illustrated in Fig. 6. B0 inhomogeneities show
similar impact for in-plane and through-plane directions:
Up to 0.5 ppm, mean absolute and semi-quantitative
perfusion measures are within 25% of the respective ref-
erence values for SNR ≥ 15. For stronger field gradients,
absolute MBF quantification appears to be more robust
than semi-quantitative measures. Misadjusted velocity
encoding has little effect on the analysis of perfusion in-
dices in the simulated case.
In vivo
An example of a dynamic perfusion image series is shown
in Fig. 7. Myocardial peak signal is observed 5–6 s after
start of the scan (7–8 s after start of injection). The three
main cardiac arteries (left anterior descending (LAD), left
circumflex (LCx), right coronary artery (RCA)) are visible
after 4 s. Summation over two time frames at myocardial
peak signal is shown for qualitative assessment of perfusion.
The LV and RV myocardium is clearly visible. Arterial
a b c
d
Fig. 3 Simulation results for BASE as function of eight SNR levels. a-c Variability of absolute and semi-quantitative perfusion measures over myocardial
sectors and 20 noise realizations. Reference values from input concentration dynamics are indicated by the solid line. Dotted lines indicate the ±25%
interval around the reference value. a Absolute myocardial blood flow (MBF) in [mL / g / min]. For SNR≥ 20 the values are confined to the ±25%
interval. b Myocardial up-slope (SLP). Above SNR = 10 no further improvement of accuracy is apparent. c Area under the curve (AUC). d Mean and
standard deviation of absolute MBF quantification over 20 noise realizations per myocardial sector
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signal leads to local hyper-intensities around the respective
vessels.
Figure 8 shows the absolute and semi-quantitative per-
fusion analysis for seven stress measurements in 4 swine.
Under in vivo conditions, the myocardial SNR across the
myocardium ranges from 11.0 ± 1.4 to 19.3 ± 2.1. Absolute
MBF quantification yielded values between 2.85 ± 0.45
and 3.74 ± 0.75 mL/g/min, with mean variations ≤10% in
repeat measurements. Normalized upslope values ranged
from 0.07 ± 0.02 to 0.09 ± 0.1 (mean intra-subject variation
≤15%), and normalized AUC values from 0.04 ± 0.01 to
0.06 ± 0.01 (mean intra-subject variation ≤40%).
Intra-myocardial coefficients of variance for MBF, upslope,
AUC and CNR were determined as 29 ± 19%, 22 ± 15%,
21 ± 13% and 11 ± 4%, respectively.
Figure 9 shows preliminary validation data obtained
from 1H gadolinium DCE imaging in three of the four
subjects. Absolute MBF quantification yielded values be-
tween 2.90 ± 0.08 and 3.75 ± 0.44 mL/g/min, with myo-
cardial SNR values ranging from 10.7 ± 0.4 to 20.6 ± 0.5.
Bland-Altman analysis revealed good agreement between
quantitative perfusion measures derived from 13C and
1H DCE image series.
Discussion
In this study, we employed extensive simulations to as-
sess experimental requirements and limitations for
absolute and semi-quantitative myocardial CMR perfu-
sion imaging using hyperpolarized [1-13C] pyruvate. We
have demonstrated that for rapid bolus injections, the
metabolic conversion into [1-13C] lactate and [13C] bi-
carbonate can largely be neglected as the information re-
lated to perfusion is contained in a very short window of
a few seconds. In vivo stress measurements in swine
suggest feasibility for the obtainable SNR and expected
parameter range with respect to metabolic kinetics and
B0 inhomogeneities.
Metabolic conversion of hyperpolarized [1-13C]
pyruvate into the downstream metabolites [1-13C] lac-
tate, [13C] bicarbonate and [1-13C] alanine is a poten-
tial hindrance to accurate perfusion assessment. The
presented simulations, however, indicate that the
myocardial response signal is only weakly affected for
rate constants kPL < 0.1 s
− 1. Based on measurements
in rat hearts [20, 21], skeletal muscle [35] and tumor
cell cultures [36] the expected in vivo values for kPL
are in the range of 0.01 s− 1 to 0.1 s− 1. Absolute MBF
quantification and the upslope perfusion index gener-
ally appear more robust towards metabolic conversion
than the AUC index. In order to improve the robust-
ness over a wider range of kinetic rate constants or
to allow slower bolus injection, combining the chem-
ically shifted signals of individual metabolites is
envisioned.
a b c
d
Fig. 4 Simulation results for variations of kinetic conversion rate parameter k for SNR = 7.5, 15 and 30. Reference values from input concentration
dynamics are indicated by the solid line. Dotted lines indicate the ±25% interval around the reference value. a Illustration of changes in myocardial
response curve with increasing k values. Faster conversion at higher values results in a reduced pyruvate signal. Downstream lactate and Bicarbonate signal
can cause signal contamination as illustrated in Fig. 2. b-c Semi-quantitative perfusion measures as function of k values analogous to Fig. 3. b Myocardial
upslope (SLP). For k values ≥0.05 the SLP index is noticeably affected. c Area under the curve (AUC). d Mean absolute MBF quantification with relative error
per myocardial sector for SNR = 15. Increasing conversion rates cause systematic underestimation of MBF. For values ≤0.1 the error is below 20%
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As described previously, the velocity-selective excita-
tion employed in this study is tailored for measurements
under stress condition with increased heart rates, con-
tractility and therefore enhanced blood velocities inside
the LV blood pool [11]. This potentially limits applicabil-
ity in patient cohorts that cannot tolerate dobutamine
infusion. Diagnostically, however, quantitative measure-
ments under stress are considered of prime diagnostic
value as early stage perfusion deficits only present at
maximum workload/vasodilation [37]. A similar work-
load dependency can also be expected for the onset of
metabolic alterations.
B0 inhomogeneities are a common problem in
hyperpolarized imaging, since relatively long readout
trajectories such as EPI are used. The lower gyromag-
netic ratio of the 13C nucleus results in comparatively
long readouts with low bandwidth in phase encoding
direction. Phase offsets from B0 inhomogeneities, as
well as motion, can cause significant signal loss due
to dephasing and geometric distortions. Different ap-
proaches for geometric distortion correction for
hyperpolarized EPI acquisitions have been proposed.
Inverting the readout direction in additional echoes
[38] or by alternating the blip direction [39] enables
the calculation of distortion maps for correction.
These methods however require tailored pulse se-
quences and full k-space sampling, as well as accurate
image-based registration of distorted images for deriv-
ing a B0 map estimate. Without distortion correction,
the presented simulations indicate underestimations
up to 30% on semi-quantitative perfusion indices for
typically achievable B0 variations of < 1.0 ppm over
the imaging volume. Absolute MBF quantification
appears more robust towards B0 inhomogeneities at
higher SNR levels with respect to mean values. How-
ever, larger B0 inhomogeneities give rise to pro-
nounced signal variations over the myocardium which
potentially limits the diagnostic value. The observed
robustness towards B0 inhomogeneities in simulations
is therefore contingent on similar signal dephasing
effects inside the AIF and myocardial compartments.
Under in vivo conditions fast flowing blood near the
aortic valve (aortic jet) and strong off-resonances in
the proximity of venous vessels can cause signal
pile-up or dephasing in the septal and lateral inferior
sectors respectively, which results in larger
intra-myocardial variability. Additionally, phase ac-
crual due to blood flow can significantly dampen the
apparent amplitude of the AIF signal and result in
underestimations of absolute MBF. Fat shift direction,
a b c
d
Fig. 5 Simulation results for variations of myocardial blood flow (MBF) in units of mL/g/min for SNR = 7.5, 15 and 30. a Calculated MBF after
reconstruction vs. simulated MBF value. Reference values used to calculate input concentration dynamics are indicated by the solid line. Dotted
lines indicate the ±25% interval around the reference value. Simulated MBF values ≤1.0 result in overestimation for all SNR levels, whereas higher
simulated MBF values are only underestimated for lower SNR levels. b-c Semi-quantitative perfusion measures as function of absolute MBF values
analogous to Fig. 3. The dotted line represents the linear regression model calculated at SNR = 50 (top left corner). b Myocardial upslope (SLP).
c Area under the curve (AUC). d Mean absolute MBF quantification with relative error per myocardial sector for SNR = 15. Strong overestimation
at low MBF values, and moderate underestimation at high MBF values is apparent
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a b c
d e f
g h i
Fig. 6 Simulation results for parameter variations with respective impact on absolute and semi-quantitative perfusion indices: a-c maximum B0
inhomogeneity in-plane. d-f B0 inhomogeneity through-plane. g-i maximum blood velocity inside the LV. Whereas B0 inhomogeneities larger
than 0.5 ppm in either direction appear to have noticeable impact on absolute and semi-quantitative perfusion measures, no systematic dependency
with respect to blood velocity is observed
Fig. 7 (left) Exemplary dynamic perfusion image series acquired in vivo. Myocardial bolus peak occurs between 4 and 6 s after start of acquisition. Arrows
indicate the left anterior descending artery (LAD) (green), left circumflex (LCx) (blue) and right coronary artery (RCA) (yellow). (right) Myocardial bolus peak
image summed over two frames. Enhanced signal in the lateral inferior segment is caused by signal leakage from the LCx and signal pile-up stemming
from geometric distortions in the EPI image due to local off-resonances
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phase encoding direction and the trigger delay need
therefore be considered carefully during planning in
vivo to avoid unnecessary artifacts.
Comparison of absolute and semi-quantitative perfu-
sion measures in simulations revealed excellent linear
relationship between MBF and upslope and AUC, re-
spectively. This confirms previous findings based on
conventional contrast agents that upslope [40, 41] and
AUC [42] are suitable surrogate indices to assess MBF
and perfusion reserve. Based on simulation results, the
upslope index appears superior to AUC for hyperpolar-
ized [1-13C] pyruvate, due to lower parameter depend-
ency overall and less bias introduced by baseline
correction steps. Of all the derived perfusion indices,
MBF showed the strongest SNR dependent variability,
especially for higher MBF values > 4 mL/g/min. These
findings suggest that in vivo measurements obtained in
this range are only accurate for relatively high SNR
values. The practically reliable measurement range for
MBF quantification is therefore subject to the achievable
SNR with a given experimental setup.
Using a plane fit for the correction of spatial variance
in receive coil sensitivity inherently assumes homoge-
neous signal intensities over the region of interest. By
choosing a time frame after initial myocardial bolus pas-
sage, the effect of impaired perfusion is reduced, as
hypo-perfused areas are characterized by delayed con-
trast agent uptake. Estimated sensitivity maps were visu-
ally inspected to ensure that the resulting sensitivity
gradient was plausible with respect to coil placement.
For clinical applications with possibly vast perfusion
deficits, a different sensitivity correction strategy might
be required.
Although the presented simulation framework reflects
image acquisition more accurately than previous work
[43], acquisitions in vivo are aggravated by additional
a
b c
Fig. 8 Perfusion indices analysed in 5 measurements in 4 swine. Repeat measurements were performed in three swine. a Sector wise absolute
and semi-quantitative perfusion indices and SNR for each measurement. Mean and standard deviation over all sectors are presented below the
respective maps. b Mean intra-myocardial Coefficient of Variance over all measurements for each perfusion index. Error bars indicate the respective
standard deviations. c Exemplary perfusion curves acquired in subject 3. Raw data points are depicted with markers; solid lines show the respective
fitted gamma-variate functions
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effects: Firstly, cardiac motion and hemodynamics can
introduce additional dephasing and distortions as well as
misregistration between image frames. Hemodynamics
are particularly important for hyperpolarized contrast
agents, as each excitation of the imaging slice saturates
part of the contrast agent bolus magnetization in the
blood compartment. In the presented simulation, this ef-
fect was neglected as the dynamics of bolus localization
and concentration are not available and would require
extensive 3D computational fluid dynamics. Improper
adjustment of the velocity selective excitation may there-
fore have stronger impact on perfusion measurements in
vivo than indicated by simulations. Other common ob-
stacles in hyperpolarized imaging in general, such as coil
combination strategies at low SNR levels without mea-
sured sensitivity maps and flip-angle miscalibration were
also omitted in this study.
Feasibility of cardiac perfusion CMR with interleaved
AIF sampling using hyperpolarized [1-13C] pyruvate was
demonstrated in vivo in swine. As predicted by simula-
tions, the achievable SNR, B0 homogeneity and expected
kinetic conversion rates appear feasible for absolute and
semi-quantitative perfusion assessment. Overall data
quality was comparable to a previous study using hyper-
polarized [13C] urea [11]. Localized phase variations
caused by the aortic jet resulted in geometric distortion
and signal pile-up artifacts in the septal region which
compromised accurate analysis in this sector. Optimiz-
ing the readout strategy is believed to be crucial in
improving overall quality of hyperpolarized perfusion
CMR. The phase sensitivity of EPI readouts could be
reduced by increasing the bandwidth along the phase
encoding direction if higher gradient system perform-
ance becomes available. Similarly, spiral readouts that
are inherently insensitive to flow artifacts require gradi-
ent specifications beyond most current clinical systems
in order to achieve sufficient resolution. Flow-compen-
sated EPI [44] could minimize motion induced artifacts,
a b
c
Fig. 9 Summary of preliminary 1H gadolinium DCE validation data acquired in n = 3 subjects under the same stress condition as the 13C measurements.
a Sector wise absolute and semi-quantitative perfusion indices and SNR for each 1H DCE measurement. Mean and standard deviation over all sectors are
presented below the respective maps. b Comparison of sector-wise perfusion indices derived from dual-bolus 1H gadolinium DCE measurements and
hyperpolarized 13C pyruvate measurements. c Exemplary perfusion curves acquired in subject 3. Raw data points are depicted with markers; solid lines
show the calculated tissue response for the fitted Fermi function
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yet results in prohibitively long readout durations and
echo times.
Full validation regarding the accuracy of quantitative
perfusion CMR using hyperpolarized pyruvate with a
gold-standard method remains to be performed. How-
ever, preliminary 1H gadolinium DCE data obtained
from the same subjects under maintained stress condi-
tion have been processed and are presented in Fig. 9.
Good agreement between the two modalities with re-
spect to mean values is found, variability is however
relatively high in both cases due to current experimental
limitations. Our current combined 13C TxRx/1H Rx coil
setup is limited in particular regarding 1H sensitivity
which in turn compromised the quality of 1H perfusion
data. In order to acquire state-of-the-art 1H images dur-
ing the same stress protocol, future validation studies
need to improve the experimental setup with respect to
1H receive coil architecture.
Although adenosine is often used as a vasodilator in
clinical stress CMR, administration protocols in swine
are still being established. The required adenosine doses
are significantly higher compared to humnan protocols
and cause systemic vasodilation and hypotension in
the porcine model [45]. These systemic side-effects
warrant additional pharmacological intervention, e.g.
with α1-adrenergic receptor agonists [46, 47]. In this
proof-of-principle study, dobutamine was hence used
for the ease of inducing a strong vasodilatory response
[48, 49]. Accordingly, the 1H perfusion protocols had to
be adjusted to cope with high heart rates during do-
butamine stress CMR, which also required compro-
mises regarding the optimal saturation delay in the
1H perfusion sequence. Upon translation of our work
to humans, adenosine will be the preferred stressor
and hence clinically tested 1H perfusion protocols are
applicable.
The quantification methods used for 13C pyruvate data
in this study have been directly adopted from existing
methods for 1H gadolinium enhanced perfusion stress
CMR. Although initial comparison between both modal-
ities looks promising, further work is required in the de-
velopment of tailored perfusion models for 13C pyruvate.
Such improved models should not only account for dif-
ferences in molecular size and therefore permeability,
but also entail active transport over cell membranes and
possible metabolic conversion.
Conclusion
In this study, a comprehensive simulation framework to
assess requirements for accurate absolute and
semi-quantitative cardiac perfusion CMR using hyperpo-
larized [1-13C] pyruvate has been presented along with
demonstration of in vivo feasibility. With the current
translation of dissolution dynamic nuclear polarization
into humans, the assessment of myocardial perfusion
CMR with hyperpolarized [1-13C] pyruvate holds poten-
tial for the diagnosis of coronary artery and microvascu-
lar disease.
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